Partners Lp Bio Net Worth

The estimated Net Worth of Partners Lp Bio is at least $68.3 million dollars as of 1 November 2004. Partners Bio owns over 5,000 units of Biospecifics Technologies stock worth over $68,321,080 and over the last 20 years Partners sold BSTC stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Partners Bio BSTC stock SEC Form 4 insiders trading

Partners has made over 1 trades of the Biospecifics Technologies stock since 2004, according to the Form 4 filled with the SEC. Most recently Partners bought 5,000 units of BSTC stock worth $8,050 on 1 November 2004.

The largest trade Partners's ever made was buying 5,000 units of Biospecifics Technologies stock on 1 November 2004 worth over $8,050. On average, Partners trades about 2,500 units every 0 days since 2004. As of 1 November 2004 Partners still owns at least 771,728 units of Biospecifics Technologies stock.

You can see the complete history of Partners Bio stock trades at the bottom of the page.

What's Partners Bio's mailing address?

Partners's mailing address filed with the SEC is 1 MEADOW DRIVE, , LAWRENCE, NY, 11559.

Insiders trading at Biospecifics Technologies

Over the last 33 years, insiders at Biospecifics Technologies have traded over $67,860,045 worth of Biospecifics Technologies stock and bought 7,761,661 units worth $656,708,120 . The most active insiders traders include Capital Management, Llc Kol..., International Plc Endo et Max Link. On average, Biospecifics Technologies executives and independent directors trade stock every 73 days with the average trade being worth of $6,538,649. The most recent stock trade was executed by International Plc Endo on 2 December 2020, trading 7,344,955 units of BSTC stock currently worth $650,028,518.

What does Biospecifics Technologies do?

Complete history of Partners Bio stock trades at Biospecifics Technologies

Biospecifics Technologies executives and stock owners

Biospecifics Technologies executives and other stock owners filed with the SEC include:

• Jennifer Chao,
  Independent Chairman of the Board
• Michael Schamroth,
  Independent Director
• Paul Gitman,
  Independent Director
• Mark Wegman,
  Director
• Toby Wegman,
  Director
• Sarah McCabe,
  Stern Investor Relations
• Michael Sherman,
  Independent Director
• Corey Fishman,
  Independent Director
• Alex Monteith,
  Senior Vice President and Chief Business Officer
• Patrick Hutchison,
  Chief Financial Officer
• Joseph Truitt,
  Chief Executive Officer, Director
• Jeffrey Kenneth Vogel,
  
• Jyrki Mattila,
  Director
• Thomas Wegman,
  President
• Of Edwin H. Wegman Estate,
  10% owner
• Patrick M Caldwell,
  Principal Financial Officer
• Partners Lp Bio,
  10% owner
• Albert Horcher,
  
• Lawrence Dobroff,
  CFO
• Max Link,
  Director
• Henry Morgan,
  Director
• George M Gould,
  Director
• Matthew Geller,
  Director
• Capital Management, Llc Kol...,
  
• Capital Management, Llcra C...,
  
• Capital Management, Llcaldr...,
  
• Capital Management, Llc Kol...,
  
• Capital Management, Llcra C...,
  
• J Kevin Buchi,
  Chief Executive Officer
• International Plc Endo,
  10% owner